scispace - formally typeset
K

Knut Woltjen

Researcher at Kyoto University

Publications -  75
Citations -  8083

Knut Woltjen is an academic researcher from Kyoto University. The author has contributed to research in topics: Induced pluripotent stem cell & Reprogramming. The author has an hindex of 29, co-authored 69 publications receiving 7048 citations. Previous affiliations of Knut Woltjen include University of Calgary & International Practical Shooting Confederation.

Papers
More filters
Journal ArticleDOI

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

TL;DR: It is shown that the individual PB insertions can be removed from established iPS cell lines, providing an invaluable tool for discovery, and the traceless removal of reprogramming factors joined with viral 2A sequences delivered by a single transposon from murine iPS lines is demonstrated.
Journal ArticleDOI

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

TL;DR: It is shown that non-viral transfection of a single multiprotein expression vector, which comprises the coding sequences of c-Myc, Klf4, Oct4 and Sox2 linked with 2A peptides, can reprogram both mouse and human fibroblasts and can be removed once reprogramming has been achieved.
Journal ArticleDOI

Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming

TL;DR: A multistep mechanism that incorporates a BMP-miRNA-MET axis during somatic cell reprogramming is defined that is linked to B MP-dependent induction of miR-205 and themiR-200 family of microRNAs that are key regulators of MET.
Journal ArticleDOI

Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation

TL;DR: It is demonstrated that iPSCs derived from Dox-withdrawn kidney tumor cells give rise to nonneoplastic kidney cells in mice, proving that they have not undergone irreversible genetic transformation and suggest that epigenetic regulation associated with iPSC derivation may drive development of particular types of cancer.